Pricing Log in Create free account

ADC Therapeutics SA (ADCT) vs Entrada Therapeutics, Inc. (TRDA)

ADC Therapeutics SA and Entrada Therapeutics, Inc. are both Biotechnology companies. ADC Therapeutics SA and Entrada Therapeutics, Inc. are of similar size ($190.2M and $186.1M). ADC Therapeutics SA grew revenue faster over the last twelve months: 3.03% against −94.1%. ADC Therapeutics SA has the higher net margin (−121.8% vs −3,537.7%) and the higher return on invested capital (0.00% vs −1,060.2%). Across the 16 metrics below, ADC Therapeutics SA leads on 13 and Entrada Therapeutics, Inc. on 3.

Valuation

Metric ADCT TRDA Biotechnology median
P/E n/m n/m 8.50
P/S 2.75 39.28 9.71
P/B n/m 0.79 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.22 0.64
EV/Sales 1.46 (8.31) 9.21
Earnings yield (46.81%) (90.83%) (33.15%)
Free cash flow yield (46.54%) (72.98%) (25.50%)

Profitability

Metric ADCT TRDA Biotechnology median
Gross margin 88.86% 100.00% 65.16%
Operating margin (125.08%) (3,767.07%) 0.00%
Net margin (121.77%) (3,537.73%) 0.00%
Free cash flow margin (127.72%) (2,867.07%) 0.00%
Return on equity 45.35% (54.09%) (56.36%)
Return on assets (32.25%) (44.35%) (48.04%)
Return on invested capital 0.00% (1,060.24%) 0.00%

Growth

Metric ADCT TRDA Biotechnology median
Revenue growth (TTM) 3.03% (94.10%) 6.02%
EPS growth (last fiscal year) 30.86% (306.55%) 30.26%
Revenue growth, 5-year CAGR 103.35% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADCT TRDA Biotechnology median
Debt to equity (0.51) 0.00 0.00
Current ratio 3.03 10.89 4.72
Net debt to EBITDA 1.22 1.88 0.96

Dividend

Metric ADCT TRDA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ADCT TRDA Biotechnology median
Market cap 190.23m 186.12m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack